Literature DB >> 14895885

Orbital X-ray therapy of progressive exophthalmos.

A JONES.   

Abstract

Keywords:  EXOPHTHALMOS

Mesh：

Year:  1951        PMID： 14895885     DOI： 10.1259/0007-1285-24-288-637

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  10 in total

Review 1.  Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.

Authors:  Kimberley P Cockerham; John S Kennerdell
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Discussion on present-day views on the treatment of thyroid condition (other than cancer).

Authors:  R V HUDSON
Journal:  Proc R Soc Med       Date:  1959-03

3.  Progressive exophthalmos.

Authors:  H C NAFFZIGER
Journal:  Ann R Coll Surg Engl       Date:  1954-07       Impact factor: 1.891

Review 4.  Radiotherapy and ophthalmology: time for a friendly re-acquaintance.

Authors:  P N Plowman
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

5.  Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X.

Authors:  A N Harnett; D Doughty; A Hirst; P N Plowman
Journal:  Br J Ophthalmol       Date:  1988-04       Impact factor: 4.638

Review 6.  Endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1972-02-05

7.  Progress in endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1979-04-14

8.  Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Authors:  L Bartalena; C Marcocci; C A Gorman; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

9.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988

10.  [Endocrine orbitopathy: comparison of the long-term result and classification after radiotherapy].

Authors:  M H Seegenschmiedt; L Keilholz; G Gusek-Schneider; S Barth; J Hensen; F Wolf; G O Naumann; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 4.033
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.